APA (7th ed.) Citation

M, T., T, M., & R, K. (2026). Therapeutic Targets for Overcoming BCR: :ABL1 Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia. Oncology research, 34(5), 7. https://doi.org/10.32604/or.2025.075217

Chicago Style (17th ed.) Citation

M, Tsubaki, Matsuo T, and Komori R. "Therapeutic Targets for Overcoming BCR: :ABL1 Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia." Oncology Research 34, no. 5 (2026): 7. https://doi.org/10.32604/or.2025.075217.

MLA (9th ed.) Citation

M, Tsubaki, et al. "Therapeutic Targets for Overcoming BCR: :ABL1 Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia." Oncology Research, vol. 34, no. 5, 2026, p. 7, https://doi.org/10.32604/or.2025.075217.